Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gisvold, S. E.
Right arrow Articles by Alexander, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gisvold, S. E.
Right arrow Articles by Alexander, H.

Stroke, Vol 15, 803-812, Copyright © 1984 by American Heart Association


ARTICLES

Multifaceted therapy after global brain ischemia in monkeys

SE Gisvold, P Safar, G Rao, J Moossy, S Kelsey and H Alexander

The pathophysiology of postischemic encephalopathy is complex, and includes tissue acidosis, edema, hypoperfusion, membrane dysfunction, impaired energy production, and possibly hypermetabolism. We tested the hypothesis that this multifactorial clinical problem must be approached with multifaceted therapy, with specific treatment aimed at each of the above postischemic changes. Eighteen minutes of complete global brain ischemia was produced with a higher pressure neck cuff in pigtailed monkeys. Control treatment postischemia (n = 9): 1) Normotension (MAP greater than or equal to 80 mmHg) restored within 2 min postischemia, 2) controlled ventilation for 24 hours with PaCO2 = 25 mmHg, 3) normothermia, and 4) phenytoin seizure prophylaxis from 20 hours postischemia. Experimental treatment (n = 10): Control treatment plus the following modifications: 1) Hemodilution to hematocrit 25% at 1-4 min postischemia, 2) brief hypertension (MAP 130 mmHg for 5 min) after accomplished hemodilution, 3) hypothermia for 6 hours, 4) pentobarbital 30 mg/kg i.v., 5) dexamethasone 4 mg/kg i.v. Outcome was evaluated at 96 hours postischemia by overall performance categories (OPC) (OPC I = normal, OPC V = brain death), neurologic deficit (ND) scores (100% ND = brain death, 0% ND = normal), and histologic damage scores of the brains. Results: Brain death developed in 1/9 control and 0/10 treated animals. The number of awake monkeys (OPC I and II) at 96 hours postischemia was significantly higher in the treated group (7/10) than in the control group (2/9) (p = 0.05). The median ND scores for the two groups were 16 and 35% respectively (p greater than 0.05). The results strongly suggest that postischemic treatment may be beneficial and that a multifaceted therapeutic approach is worth pursuing.


This article has been cited by other articles:


Home page
StrokeHome page
A. Zeiner, M. Holzer, F. Sterz, W. Behringer, W. Schorkhuber, M. Mullner, M. Frass, P. Siostrzonek, K. Ratheiser, A. Kaff, et al.
Mild Resuscitative Hypothermia to Improve Neurological Outcome After Cardiac Arrest : A Clinical Feasibility Trial
Stroke, January 1, 2000; 31(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. H. Idris, L. B. Becker, J. P. Ornato, J. R. Hedges, N. G. Bircher, N. C. Chandra, R. O. Cummins, W. Dick, U. Ebmeyer, H. R. Halperin, et al.
Utstein-Style Guidelines for Uniform Reporting of Laboratory CPR Research: A Statement for Healthcare Professionals From a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine
Circulation, November 1, 1996; 94(9): 2324 - 2336.
[Full Text]